Charles River LaboratoriesCRL
NYSE · USA · Segment 4 of 8 in the Medicine, pharma & life science value chain: CDMO & pharma manufacturing
American provider of preclinical research and testing services for pharma and biotech — models and laboratory services throughout drug development.
CDMO & pharma manufacturing: Contract development and manufacturing of medicines — the industrial backbone behind the drugs.
Key metrics
Market cap
$11.1B
Price
$233.38
Today
−0.1%
Return YTD
+17.1%
Return 1Y
+46.9%
P/E
—
P/S
2.8
P/B
3.8
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Preclinical models
- Safety testing
- Cell & gene therapy services
Competitors
- ICON
- IQVIA
- Labcorp
Risks
- Biotech funding cycles
- Regulatory changes (animal models)
Same segment: CDMO & pharma manufacturing
See where Charles River Laboratories sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →